Delivery Order SPE2DE21D0007-SPE2D625F17J5

Award Date 11/26/24
Potential Completion Date 12/2/24
Potential Value $1.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a fixed-price delivery order contract awarded by the Medical Supply Chain, a defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,073.80 contract is for the supply of ANTI-JKB BIOCLONE 1X3ML, a critical medical diagnostic product. The contract has a January 30, 2025 completion date and does not utilize any set-aside designations, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture...
This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical, a subcomponent of the Defense Health Agency, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $3,988.40 fixed-price with economic price adjustment contract is for the delivery of 4564177392 ANTI-JKA BIOCLONE 1X3ML by April 10, 2024. Ortho-Clinical Diagnostics has provided medical equipment, reagents, consumables, and testing services to various federal agencies, including the...
This is a federal contract award from the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract, valued at $3,661.19, is for the delivery of anti-JKA bioclone diagnostic equipment. It is a fixed-price delivery order with economic price adjustments, with a performance period ending on March 13, 2025. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical...
Ortho-Clinical Diagnostics Inc. has been awarded a $2,492.75 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery contract for 4563113699 ANTI-JKA BIOCLONE 1X3ML. The delivery order has a completion date of December 19, 2023 and was awarded on December 14, 2023. The contract has a fixed price with economic price adjustment pricing structure and performance will take place in Raritan, New Jersey. No set-aside designation was applied to this award....
Ortho-Clinical Diagnostics Inc. was awarded a delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical on August 30, 2023. The fixed price with economic price adjustment order, valued at approximately $536, is for the delivery of ANTI-JKB bioclones in 1x3ml packages and has a period of performance through September 5, 2023. The place of performance is Raritan, New Jersey. No set-aside provisions were applied to this order to...
This is a $1,162.82 fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support (DLA TROOP SUPPORT) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The order is for anti-S 1x3ml supplies and has an ultimate completion date of January 13, 2025. Ortho-Clinical Diagnostics has provided medical equipment, reagents, and testing services to various federal agencies under fixed-price,...
This is a delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract has a ceiling value of $1,832.54 and is for the delivery of ANTI-B BIOCLONE 15X10ML medical supplies. It is a fixed-price contract with economic price adjustment and does not have any set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture...
This is a $1,184.96 fixed-price delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The order is for the supply of an "Anti-E Bioclone 1x5ML" product, with an ultimate completion date of August 8, 2024. Ortho-Clinical Diagnostics is a provider of diagnostic solutions, including products and services for federal healthcare programs such as the Department of Veterans Affairs and Department of Defense....
This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract is for the supply of Anti-A Bioclone 15x10ml, a critical medical diagnostic product, with a ceiling value of $1,832.54 and a period of performance through March 25, 2025. The contract is a fixed-price agreement with economic price adjustment and does not have a set-aside designation,...
This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,832.54 contract is for the delivery of 4,565,172,008 units of an anti-B bioclone product. The contract has a period of performance through July 19, 2024 and does not have a set-aside designation. Ortho-Clinical Diagnostics is a for-profit company that has provided medical equipment, reagents, and testing services to various federal...
  • SPE2DE21D0007
    Indefinite Delivery Contract
  • SPE2DE21D0007-SPE2D625F17J5
    Delivery Order

This is a delivery order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the supply of 4566560065 Anti-JKB Bioclone 1x3ml units. The contract has a fixed price with economic price adjustment pricing type, a ceiling value of $1,073.80, and a period of performance extending to December 2, 2024. Ortho-Clinical Diagnostics has provided medical equipment, reagents, consumables, and testing services to various federal agencies in the past, including the Department of Veterans Affairs, Defense Health Agency, and Department of Health and Human Services. This award is not associated with a set-aside program.

Generated 2/25/25, 9:53 AM